Service de Médecine Interne
Paris, 75020, France
NCT Number: NCT05292768
Autoinflammatory diseases (AID) are caused by innate immunity dysregulation. AID pathophysiology is only partly understood, especially in the case of unclassified AID. Mast cells (MC) are innate immune cells associated with a spectrum of disease between systemic mastocytosis and mast cell activation syndrome. The implication of MC has been shown in cryopyrin associated periodic syndrome (CAPS).Our aim is to evaluate the involvement of MC in AID by assessing clinical and biological signs of MC activation and studying cutaneous and digestive biopsies.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Paris, 75020, France
Autoinflammatory diseases (AID) are caused by innate immunity dysregulation and characterized by recurrent bouts of fever, frequently associated with digestive, articular or cutaneous symptoms, and sometimes ocular, auricular or neurologic inflammation. The most frequent monogenic AID is Familial Mediterranean fever (FMF).
Despite recent genetic progress AID pathophysiology is only partly understood, especially in the case of unclassified AID.
Mast cells (MC) are innate immune cells associated with a spectrum of disease between systemic mastocytosis and mast cell activation syndrome (MCAS). In MCAS, patients have various symptoms including abdominal pain, bloating, pruritus, flush, anxiety, fatigue, among which some are similar to those seen in patients with AID. The implication of MC has been shown in cryopyrin associated periodic syndrome (CAPS).
Our hypothesis is that MC could be involved in AID pathophysiology,
In order to test this hypothesis, we plan to study :
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at inclusion
presence of clinical and biological markers of MCAS
Time frame: at inclusion
we will compare clinical symptoms of MC activation between AID patients and other groups
Time frame: at inclusion
determine which MC mediators are elevated in AID and if they correlate with inflammation
Time frame: at inclusion, retrospectively
we will study MC infiltration in digestive, renale and cutaneous biopsies from patients with AID and compare them with biopsies from the other groups from subgroups of patients who had a biopsy performed.
Time frame: at inclusion, retrospectively
we will study basophilic polynuclear activation from blood samples of AID patients
Contact information is provided by the study sponsor or research team.
Nabiha Sbeih, MD
CONTACT
Sophie GEORGIN-LAVIALLE, PU-PH
CONTACT
+33 (0)1 56 01 72 04 or 60 77
Assistance Publique - Hôpitaux de Paris
Other
Acronym: INFLAMAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06971289
Autoinflammatory Disease
View Trial DetailsNCT07126145
Arthritis, Arthritis, Juvenile
View Trial DetailsNCT00059748
Autoinflammatory Disease, Connective Tissue Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06004349
Autoimmune Disease, Autoimmune Diseases
New York, United States
View Trial Details